China Sxt Pharmaceuticals Stock Price Prediction

SXTC Stock  USD 0.40  0.01  2.44%   
At the present time, the relative strength index (RSI) of China SXT's share price is approaching 34. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling China SXT, making its price go up or down.

Oversold Vs Overbought

34

 
Oversold
 
Overbought
The successful prediction of China SXT's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with China SXT Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting China SXT's stock price prediction:
Quarterly Earnings Growth
0.426
Quarterly Revenue Growth
0.295
Using China SXT hype-based prediction, you can estimate the value of China SXT Pharmaceuticals from the perspective of China SXT response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in China SXT to buy its stock at a price that has no basis in reality. In that case, they are not buying China because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

China SXT after-hype prediction price

    
  USD 0.44  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out China SXT Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of China SXT's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.020.386.79
Details
Naive
Forecast
LowNextHigh
0.010.436.84
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.370.390.41
Details

China SXT After-Hype Price Prediction Density Analysis

As far as predicting the price of China SXT at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in China SXT or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of China SXT, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

China SXT Estimiated After-Hype Price Volatility

In the context of predicting China SXT's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on China SXT's historical news coverage. China SXT's after-hype downside and upside margins for the prediction period are 0.02 and 6.85, respectively. We have considered China SXT's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.40
0.44
After-hype Price
6.85
Upside
China SXT is out of control at this time. Analysis and calculation of next after-hype price of China SXT Pharmaceuticals is based on 3 months time horizon.

China SXT Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as China SXT is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China SXT backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with China SXT, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.52 
6.41
  0.04 
  0.03 
3 Events / Month
9 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.40
0.44
10.00 
9,157  
Notes

China SXT Hype Timeline

China SXT Pharmaceuticals is at this time traded for 0.40. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.03. China is anticipated to increase in value after the next headline, with the price projected to jump to 0.44 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 10.0%, whereas the daily expected return is at this time at -0.52%. The volatility of related hype on China SXT is about 10321.19%, with the expected price after the next announcement by competition of 0.43. The company has return on total asset (ROA) of (0.0497) % which means that it has lost $0.0497 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2165) %, meaning that it created substantial loss on money invested by shareholders. China SXT's management efficiency ratios could be used to measure how well China SXT manages its routine affairs as well as how well it operates its assets and liabilities. As of November 30, 2024, Return On Tangible Assets is expected to decline to -0.14. The current year's Return On Capital Employed is expected to grow to -0.17. At present, China SXT's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 34.3 K, whereas Total Assets are forecasted to decline to about 21.9 M. Given the investment horizon of 90 days the next anticipated press release will be in about 3 days.
Check out China SXT Basic Forecasting Models to cross-verify your projections.

China SXT Related Hype Analysis

Having access to credible news sources related to China SXT's direct competition is more important than ever and may enhance your ability to predict China SXT's future price movements. Getting to know how China SXT's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how China SXT may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AKANAkanda Corp(0.06)2 per month 0.00 (0.10) 8.00 (6.67) 22.55 
PTPIPetros Pharmaceuticals(0.02)4 per month 0.00 (0.06) 7.41 (7.89) 45.54 
GSACGelStat Corp 0.00 0 per month 11.65  0.08  33.33 (25.00) 58.33 
SHPHShuttle Pharmaceuticals 0.07 4 per month 0.00 (0.13) 10.08 (10.70) 50.96 
QLIQilian International Holding 1.35 3 per month 6.62  0.16  19.23 (12.37) 61.58 
PRFXPainreform 0.20 5 per month 10.59  0.01  13.13 (19.48) 187.40 
RGCRegencell Bioscience Holdings(0.20)10 per month 6.48 (0.01) 22.58 (10.93) 43.32 
PROCProcaps Group SA 0.00 0 per month 8.79  0.03  26.19 (13.75) 111.85 
JUPWJupiter Wellness 0.02 3 per month 4.91  0.04  8.57 (9.62) 61.38 
BFRIBiofrontera(0.06)6 per month 7.25  0  14.63 (11.70) 46.72 
HUGEFSD Pharma Class 0.01 5 per month 0.00 (0.07) 9.38 (13.33) 155.75 
ACORAcorda Therapeutics 0.00 0 per month 5.26  0.08  14.01 (9.57) 95.04 
LSDILucy Scientific Discovery(0.18)1 per month 27.98  0.21  550.00 (81.82) 3,998 
SGIOYShionogi Co Ltd 0.00 0 per month 0.00 (0.23) 1.63 (2.09) 5.10 
SBFMSunshine Biopharma 0.04 2 per month 3.85 (0.0004) 6.97 (6.29) 34.79 
ALIMAlimera Sciences 0.01 7 per month 0.37  0.12  3.28 (0.72) 82.36 
GHSIGuardion Health Sciences 0.00 0 per month 8.11  0.05  18.66 (7.94) 101.05 
CPHIChina Pharma Holdings 0.00 7 per month 4.79  0.01  9.09 (11.11) 43.71 
HCANFHalo Collective 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

China SXT Additional Predictive Modules

Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About China SXT Predictive Indicators

The successful prediction of China SXT stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as China SXT Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of China SXT based on analysis of China SXT hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to China SXT's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to China SXT's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding689.27248.91254.83327.46
PTB Ratio0.350.130.10.0982

Story Coverage note for China SXT

The number of cover stories for China SXT depends on current market conditions and China SXT's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that China SXT is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about China SXT's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

China SXT Short Properties

China SXT's future price predictability will typically decrease when China SXT's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of China SXT Pharmaceuticals often depends not only on the future outlook of the potential China SXT's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China SXT's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding867.4 K
Cash And Short Term Investments12.1 M

Complementary Tools for China Stock analysis

When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets